Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma
Christopher L. Bowlus, Lionel Arrivé, Annika Bergquist, et al.
Hepatology (2022) Vol. 77, Iss. 2, pp. 659-702
Open Access | Times Cited: 161

Showing 1-25 of 161 citing articles:

Surveillance of primary sclerosing cholangitis – a comparison of scheduled or on-demand ERCP with annual MRI surveillance: a multicenter study
Nina Barner‐Rasmussen, Antonio Molinaro, Bregje Mol, et al.
Endoscopy (2025)
Closed Access | Times Cited: 1
The gut ecosystem and immune tolerance
Tihong Shao, Ronald Hsu, Desiree L. Rafizadeh, et al.
Journal of Autoimmunity (2023) Vol. 141, pp. 103114-103114
Open Access | Times Cited: 40
Inflammatory bowel disease and primary sclerosing cholangitis: One disease or two?
Kim N. van Munster, Annika Bergquist, Cyriel Y. Ponsioen
Journal of Hepatology (2023) Vol. 80, Iss. 1, pp. 155-168
Open Access | Times Cited: 30
ChatGPT on guidelines: Providing contextual knowledge to GPT allows it to provide advice on appropriate colonoscopy intervals
Daniel Yan Zheng Lim, Yu Bin Tan, Jonathan Tian En Koh, et al.
Journal of Gastroenterology and Hepatology (2023) Vol. 39, Iss. 1, pp. 81-106
Closed Access | Times Cited: 29
Primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD): a condition exemplifying the crosstalk of the gut–liver axis
You Sun Kim, Edward Hurley, Yoojeong Park, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 7, pp. 1380-1387
Open Access | Times Cited: 28
New Challenges in the Management of Cholangiocarcinoma: The Role of Liver Transplantation, Locoregional Therapies, and Systemic Therapy
Ezequiel Mauro, Joana Ferrer, Tamara Saurí, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1244-1244
Open Access | Times Cited: 25
Recent Advances in the Management of Primary Sclerosing Cholangitis
David N. Assis, Christopher L. Bowlus
Clinical Gastroenterology and Hepatology (2023) Vol. 21, Iss. 8, pp. 2065-2075
Open Access | Times Cited: 24
Immunology of bile acids regulated receptors
Stefano Fiorucci, Silvia Marchianò, Ginevra Urbani, et al.
Progress in Lipid Research (2024) Vol. 95, pp. 101291-101291
Closed Access | Times Cited: 11
ACG Clinical Guideline: Focal Liver Lesions
Catherine Frenette, Mishal Mendiratta‐Lala, Reena Salgia, et al.
The American Journal of Gastroenterology (2024) Vol. 119, Iss. 7, pp. 1235-1271
Closed Access | Times Cited: 8
Effectiveness and safety of oral vancomycin for the treatment of inflammatory bowel disease associated with primary sclerosing cholangitis: a systematic review and pooled analysis
Wassel Sannaa, Mazen Almasry, Mustafa Peedikayil, et al.
Therapeutic Advances in Gastroenterology (2025) Vol. 18
Open Access | Times Cited: 1
Artificial Intelligence Applications in Hepatology
Jörn M. Schattenberg, Naga Chalasani, Naim Alkhouri
Clinical Gastroenterology and Hepatology (2023) Vol. 21, Iss. 8, pp. 2015-2025
Open Access | Times Cited: 21
Development of a Liver Disease-Specific Large Language Model Chat Interface using Retrieval Augmented Generation
Jin Ge, Steve Sun, Joseph F. Owens, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 19
Chemotherapy with or without selective internal radiation therapy for intrahepatic cholangiocarcinoma: Data from clinical trials
Julien Edeline, John Bridgewater, Boris Campillo‐Gimenez, et al.
Hepatology (2023) Vol. 79, Iss. 1, pp. 96-106
Closed Access | Times Cited: 17
Microwave ablation versus liver resection for primary intrahepatic cholangiocarcinoma within Milan criteria: a long-term multicenter cohort study
Chuan Pang, Jianming Li, Jianping Dou, et al.
EClinicalMedicine (2024) Vol. 67, pp. 102336-102336
Open Access | Times Cited: 7
Efficacy and safety of biologics in primary sclerosing cholangitis with inflammatory bowel disease: A systematic review and meta-analysis
Ayesha Shah, Michael Jones, Gavin Callaghan, et al.
Hepatology Communications (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 6
Early-Onset Gastrointestinal Malignancies: An Investigation into a Rising Concern
Aayush Vishwanath, Shreyas Krishna, Albert Manudhane, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1553-1553
Open Access | Times Cited: 5
IL-17 signaling in primary sclerosing cholangitis patient-derived organoids
A. Moreno, Maria Eugenia Guicciardi, Alexander Q. Wixom, et al.
Hepatology Communications (2024) Vol. 8, Iss. 6
Open Access | Times Cited: 5
KASL Clinical Practice Guidelines for Noninvasive Tests to Assess Liver Fibrosis in Chronic Liver Disease
Mi Na Kim, Ji Won Han, Jihyun An, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. Suppl, pp. S5-S105
Open Access | Times Cited: 5
Primary Sclerosing Cholangitis: Diagnostic Criteria
Nora Cazzagon, Samantha Sarcognato, Elisa Catanzaro, et al.
Tomography (2024) Vol. 10, Iss. 1, pp. 47-65
Open Access | Times Cited: 4
NGS of brush cytology samples improves the detection of high-grade dysplasia and cholangiocarcinoma in patients with primary sclerosing cholangitis: A retrospective and prospective study
Sonja Boyd, Taru Mustamäki, Nelli Sjöblom, et al.
Hepatology Communications (2024) Vol. 8, Iss. 4
Open Access | Times Cited: 4
Update on the Screening, Diagnosis, and Management of Cholangiocarcinoma.
Sudha Kodali, Ashton A. Connor, Elizabeth W. Brombosz, et al.
PubMed (2024) Vol. 20, Iss. 3, pp. 151-158
Closed Access | Times Cited: 4
Liver GPBAR1 Associates With Immune Dysfunction in Primary Sclerosing Cholangitis and Its Activation Attenuates Cholestasis in Abcb4−/− Mice
Cristina Di Giorgio, Ginevra Urbani, Silvia Marchianò, et al.
Liver International (2025) Vol. 45, Iss. 2
Open Access
Current Treatment Regimens and Promising Molecular Therapies for Chronic Hepatobiliary Diseases
Marilena Durazzo, Arianna Ferro, Víctor Navarro-Tableros, et al.
Biomolecules (2025) Vol. 15, Iss. 1, pp. 121-121
Open Access
Application value of 18F-FDG PET/CT in soft tissue metastasis of intrahepatic cholangiocarcinoma: a case report and literature review
Yan Liu, Xiaohui Sun, Yü Liu, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Assessing patient-reported outcomes in primary sclerosing cholangitis: an update
Donna M. Evon, Bryce B. Reeve
Current Opinion in Gastroenterology (2025)
Closed Access
Page 1 - Next Page

Scroll to top